Gilead Sciences, Inc. (GILD)

Gilead Sciences Revenue

In the year 2023, Gilead Sciences had annual revenue of $27.12B, a decrease of -0.60%. Revenue in the quarter ending December 31, 2023 was $7.11B, a -3.72% decrease year-over-year.

• Revenue (ttm): $27.12B
• Revenue Growth: -0.60%
• P/S Ratio: 3.00
• Revenue / Employee: $1,506,444
• Employees: 18,000
• Market Cap: 81.46B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%
Dec 31, 2019	22.45B	322.00M	1.46%
Dec 31, 2018	22.13B	-3.98B	-15.24%
Dec 31, 2017	26.11B	-4.28B	-14.09%
Dec 31, 2016	30.39B	-2.25B	-6.89%
Dec 31, 2015	32.64B	7.75B	31.13%
Dec 31, 2014	24.89B	13.69B	122.19%
Dec 31, 2013	11.20B	1.50B	15.46%
Dec 31, 2012	9.70B	1.32B	15.70%
Dec 31, 2011	8.39B	435.97M	5.48%
Dec 31, 2010	7.95B	938.04M	13.38%
Dec 31, 2009	7.01B	1.68B	31.40%
Dec 31, 2008	5.34B	1.11B	26.14%
Dec 31, 2007	4.23B	1.20B	39.78%
Dec 31, 2006	3.03B	997.74M	49.19%
Dec 31, 2005	2.03B	703.78M	53.13%
Dec 31, 2004	1.32B	456.76M	52.63%
Dec 31, 2003	867.86M	401.07M	85.92%
Dec 31, 2002	466.79M	233.02M	99.68%
Dec 31, 2001	233.77M	38.21M	19.54%
Dec 31, 2000	195.56M	26.58M	15.73%
Dec 31, 1999	168.98M	17.86M	11.82%
Dec 31, 1998	151.12M	18.86M	14.26%
Dec 31, 1997	132.26M	98.84M	295.75%
Dec 31, 1996	33.42M	28.50M	578.99%
Mar 31, 1995	4.92M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.